引用次数
引用: 45,695
H-指数: 96
I10-指数 : 340
出版物: 1,218
[Pancreatic carcinoma: progress in therapy].
Lordick F
Krankenpflege Journal 42 158
2004
Randomized Phase 3 Study of Panitumumab With FOLFIRI vs. FOLFIRI Alone as Second-Line Treatment in Patients With Metastatic Colorectal Cancer
Gansert J , André T , Peeters M , Rong A
Gastrointestinal Cancer Research : GCR
25
2010
Metabolic imaging predicts response and prognosis in neoadjuvant treated, locally advanced gastric cancer: Final results of a prospective study
Ulrich Fink , Hinrich Wieder , Karen Becker , Martin Dobritz
Society of Nuclear Medicine Annual Meeting Abstracts 48
2
2007
Prospective evaluation of FDG-PET for prediction of response and survival in AEG I/II (uT3cNany cM0)
Jorg Rudiger Siewert , Karen Becker , Markus Schwaiger , Wolfgang Weber
日本外科学会雑誌 107 ( 2) 246
2006
Initial FDG uptake in patients with adenocarcinomas of the esophagogastric junction (AEG): Is it correlated to tumor localization and to patients' survival?
Michael Souvatzoglou , Florian Lordick , Tibor Schuster , Katja Ott
The Journal of Nuclear Medicine 48
2007
Comparison of changes in tumor metabolic activity and tumor size during chemotherapy of adenocarcinomas of the esophagogastric junction.
Florian Lordick , Hinrich A Wieder , Katja Ott , Ambros J Beer
The Journal of Nuclear Medicine 46 ( 12) 2029 -2034
78
2005
The Value of PET Imaging in Patients with Localized Gastroesophageal Cancer.
Ken Herrmann , Bernd-Joachim Krause , Katja Ott , Florian Lordick
Gastrointestinal cancer research : GCR 2 ( 6) 287 -294
30
2008
Metabolic response-guided treatment individualization in neoadjuvant therapy of locally advanced adenocarcinoma of the esophagogastric junction (AEG)
Heinz Hoefler , Hinrich Wieder , Karen Becker , Markus Schwaiger
Society of Nuclear Medicine Annual Meeting Abstracts 48
1
2007
Accomplishments in 2008 in the adjuvant treatment of rectal cancer.
Brian Czito , Florian Lordick
Gastrointestinal cancer research : GCR 3
2009
Management of infusion reactions in clinical trials and beyond: the US and EU perspectives.
Anthony J Cmelak , Markus Borner , M Wasif Saif , Florian Lordick
Oncology 23 ( 2) 18 -25
10
2009
Current status and future of chemotherapy and biochemotherapy in gastroesophageal cancers.
Dirk Jäger , Florian Lordick
Gastrointestinal cancer research : GCR 2 ( 4) 187 -197
13
2008
The role of PET in predicting response to chemotherapy in oesophago-gastric cancer.
Florian Lordick
Acta Gastro-enterologica Belgica 74 ( 4) 530 -535
2
2011
Results of the REGATTA trial on surgical therapy of limited metastatic gastric cancer: open issues and future perspectives
Florian Lordick , Lena-Christin Conradi , Andreas Pircher
Translational cancer research 5 ( 2)
2016
Erste molekular stratifizierte Therapie beim Pankreaskarzinom
Florian Lordick
Im Fokus Onkologie 22 ( 5) 33 -33
2019
Phase II study of zolbetuximab plus pembrolizumab in claudin 18.2: Positive locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma (G/GEJ)—ILUSTRO Cohort 3.
Eric Van Cutsem , Peter C. Enzinger , Daniel V.T. Catenacci , David H. Ilson
Journal of Clinical Oncology 39
2021
Covid-19 in outpatients-Is fever a useful indicator for SARS-CoV-2 infection?
Christoph Lübbert , Florian Lordick , Holger Kirsten , Amrei von Braun
PLOS ONE 16 ( 2)
1
2021
FOXM1 Inhibition in Ovarian Cancer Tissue Cultures Affects Individual Treatment Susceptibility Ex Vivo.
Sonja Kallendrusch , Florian Lordick , Bahriye Aktas , Ingo Bechmann
Cancers 13 ( 5) 956
2
2021
Targeted and immunotherapy in the era of personalised gastric cancer treatment.
Florian Lordick , Silvia Catanese
Best Practice & Research in Clinical Gastroenterology 101738 -101738
2021
Symptom Burden and Palliative Care Needs of Patients with Incurable Cancer at Diagnosis and During the Disease Course
Florian Lordick , Olaf Ortmann , Karin Oechsle , Jeannette Vogt
Oncologist 26 ( 6)
25
2021
Patient-reported outcomes from the phase II FAST trial of zolbetuximab plus EOX compared to EOX alone as first-line treatment of patients with metastatic CLDN18.2+ gastroesophageal adenocarcinoma
Florian Lordick , Özlem Türeci , Ugur Sahin , Salah-Eddin Al-Batran
Gastric Cancer 24 ( 3) 721 -730
9
2021